医药与保健
醫藥與保健
의약여보건
MEDICINE AND HEALTH CARE
2014年
11期
173-173
,共1页
糖尿病肾病%前列地尔%贝那普利%尿蛋白
糖尿病腎病%前列地爾%貝那普利%尿蛋白
당뇨병신병%전렬지이%패나보리%뇨단백
diabetic nephropathy%alprostadil%benazepril%urine protein
目的:糖尿病肾病患者采用前列地尔联合那普利治疗,分析其对尿蛋白的治疗效果。方法选取我院2011年6月—2013年6月收治的78例糖尿病肾病患者,随机分为观察组和对照组,两组患者均给予贝那普利片治疗,观察组在此基础上联合前列地尔注射液进行治疗,对两组患者的治疗效果进行对比观察。结果观察组治疗有效率为92.3%,对照组治疗有效率为79.4%,观察组高于对照组,两组数据对比具有统计学意义(P<0.05)。治疗2个月后,观察组24h尿蛋白含量与24h尿微白蛋白排血率明显低于对照组,两组数据对比具有统计学意义(P<0.05)。结论糖尿病肾病患者采用前列地尔联合那普利治疗与单纯采用贝那普利治疗相比,具有显著效果,可有效降低尿蛋白含量,控制尿微白蛋白排泄率,值得临床推广。
目的:糖尿病腎病患者採用前列地爾聯閤那普利治療,分析其對尿蛋白的治療效果。方法選取我院2011年6月—2013年6月收治的78例糖尿病腎病患者,隨機分為觀察組和對照組,兩組患者均給予貝那普利片治療,觀察組在此基礎上聯閤前列地爾註射液進行治療,對兩組患者的治療效果進行對比觀察。結果觀察組治療有效率為92.3%,對照組治療有效率為79.4%,觀察組高于對照組,兩組數據對比具有統計學意義(P<0.05)。治療2箇月後,觀察組24h尿蛋白含量與24h尿微白蛋白排血率明顯低于對照組,兩組數據對比具有統計學意義(P<0.05)。結論糖尿病腎病患者採用前列地爾聯閤那普利治療與單純採用貝那普利治療相比,具有顯著效果,可有效降低尿蛋白含量,控製尿微白蛋白排洩率,值得臨床推廣。
목적:당뇨병신병환자채용전렬지이연합나보리치료,분석기대뇨단백적치료효과。방법선취아원2011년6월—2013년6월수치적78례당뇨병신병환자,수궤분위관찰조화대조조,량조환자균급여패나보리편치료,관찰조재차기출상연합전렬지이주사액진행치료,대량조환자적치료효과진행대비관찰。결과관찰조치료유효솔위92.3%,대조조치료유효솔위79.4%,관찰조고우대조조,량조수거대비구유통계학의의(P<0.05)。치료2개월후,관찰조24h뇨단백함량여24h뇨미백단백배혈솔명현저우대조조,량조수거대비구유통계학의의(P<0.05)。결론당뇨병신병환자채용전렬지이연합나보리치료여단순채용패나보리치료상비,구유현저효과,가유효강저뇨단백함량,공제뇨미백단백배설솔,치득림상추엄。
Objective To analyze the treatment effect of alprostadil combined with benazepril on urine protein in the patients with diabetic nephropathy.Methods A total of 78 cases of diabetic nephropathy patients who treated in our hospital between June 2011 to June 2013 were collected,and divided into observation group and control group.The patients in both two groups were treated with benazepril treatment,and the patients in the observation group received alprostadil injection based on it,then comparatively observed the treatment effect between two groups.Results The effective rate of the observation group (92.3%) was higher than that of the control gorup (79.4%), and there was significant difference between two groups (P<0.05).After treatment for 2 months,the urine protein content and urinary albumin excretion rate of the observation group at 24 hours were significantly lower than those of the control group, and there was significant difference between two groups (P<0.05).Conclusions The alprostadil combined with benazepril has significant effect in the treatment of diabetic nephropathy patients when compared with the single application of benazepril,it can effectively decrease the urine protein content and control urinary albumin excretion rate,which is worthy of clinical promotion.